Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

adriamycinol

Known as: 13-dihydrodoxorubicin, doxorubicinol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Background: In the fight against cancer, new drug delivery systems are attractive to improve drug targeting of tumors, maximize… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Changes in iron homeostasis have been implicated in cardiotoxicity induced by the anticancer anthracycline doxorubicin (DOX… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin were prepared as drug delivery systems. The… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE We performed a pharmacologic investigation of paclitaxel (PTX) infused over 3 hours and bolus doxorubicin (DOX) to assess… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE To study the effects of cyclosporine (CsA), a modulator of multidrug resistance (MDR), on the pharmacokinetics and… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
We have treated 14 cancer patients with liposome-encapsulated doxorubicin (LED) at doses of 30, 45, 60, and 90 mg/m2. Nausea and… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Doxorubicin (former generic name, adriamycin), a highly effective anticancer drug, produces cardiotoxicity, which limits its… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Pharmacokinetics of doxorubicin (DOX), epidoxorubicin (EPI), and their metabolites in plasma have been performed in eight… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Doxorubicin (adriamycin) is a highly effective cancer chemotherapeutic drug but its clinical utility is limited by its… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1983
Highly Cited
1983
The plasma pharmacokinetics of Adriamycin and adriamycinol following a 15-min infusion of 75 mg/sq m of Adriamycin were studied… Expand
  • table 1
  • table 2
Is this relevant?